Agoraphobia Recovery: What Improvement Looks Like and Why Avoidance Matters
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: October 1, 2026 · Editorial Policy
Agoraphobia recovery is best understood as a widening of life: less avoidance, greater freedom of movement, more flexible behavior, and less need to organize everyday decisions around escape, rescue, or prevention of feared symptoms. Fewer panic attacks can be part of improvement, but panic-free status is not the only meaningful endpoint. A person may still feel anxiety and nevertheless be recovering if they can enter situations they previously avoided, stay engaged when discomfort rises, and resume work, study, relationships, travel, errands, health care, or time alone that fear had restricted.
That focus follows the clinical structure of agoraphobia. Agoraphobia is an anxiety or fear-related disorder organized around marked fear or anxiety in situations where escape may feel difficult or help may seem unavailable if panic-like or other incapacitating or embarrassing symptoms occur. The World Health Organization’s ICD-11 Clinical Descriptions and Diagnostic Requirements and the National Institute of Mental Health describe a recognizable situational fear-and-avoidance pattern rather than a generic fear of leaving home. Agoraphobia can occur with or without panic disorder.
Recovery evidence has an important limitation. Many influential treatment and long-term follow-up studies used older diagnostic systems and enrolled people with panic disorder with agoraphobia, or mixed panic-disorder samples with and without agoraphobia. Those studies are highly relevant to avoidance, exposure, functioning, relapse, and maintenance of gains, but their numerical outcomes are not precise modern prognosis estimates for every person with standalone DSM-5-TR or ICD-11 agoraphobia.
This article therefore owns one specific intent: what improvement in agoraphobia looks like, why residual avoidance matters, how setbacks differ from relapse, how progress can be followed, and why recovery is broader than simply having fewer anxious moments. It does not replace the full agoraphobia treatment guide or the dedicated explanation of graded exposure for agoraphobia.
What Does Recovery From Agoraphobia Mean?
There is no single universally accepted agoraphobia-specific definition of recovery. Research studies use terms such as response, remission, recovery, relapse, and recurrence in different ways. A treatment response usually means a clinically meaningful reduction in symptoms. Remission usually means that symptoms fall below a specified diagnostic or severity threshold. Recovery is often used more broadly for sustained improvement in symptoms and functioning. In everyday life, the most useful question is whether agoraphobia still organizes the person’s choices.
A multidimensional view is therefore more informative than any single symptom count. Recovery can include less situational fear, less anticipatory anxiety, less overt avoidance, reduced dependence on rigid safety conditions, greater confidence in coping, wider mobility, improved role functioning, and a greater ability to tolerate uncertainty about whether anxiety will appear.
Recovery is not the same as feeling calm everywhere
A person can make substantial progress while still experiencing fear. Someone who rides a train while anxious, enters a store without a companion despite discomfort, or stays at an appointment after an urge to leave is doing something clinically different from someone whose anxiety is lower only because feared situations remain excluded from daily life. Symptom intensity matters, but behavior and functioning show whether the person’s world is actually expanding.
This distinction fits modern exposure models. Craske and colleagues describe exposure as a process of new learning rather than simple erasure of fear. Old threat associations can remain retrievable while new learning develops: the feared situation can be approached, the predicted catastrophe may not occur, and distress can be tolerated without automatic escape. Recovery therefore does not require every exposure to end with zero anxiety.
Why Avoidance Matters So Much in Agoraphobia Recovery
Avoidance is central to agoraphobia. It can produce immediate relief, which makes it powerful: leaving a crowded store, canceling a trip, staying close to home, choosing only easily escapable seats, or waiting for a trusted companion may rapidly reduce distress. That short-term relief can reinforce the escape or avoidance response, making the same choice more likely the next time fear appears. The broader learning cycle is explained in Anxiety and Avoidance: How Avoidance Maintains Fear.
Avoidance also changes what the person gets to learn. If a feared situation is never entered, or is always exited at the first rise in anxiety, the prediction that the situation is unmanageable remains largely untested. A person can know intellectually that a bus, supermarket, line, elevator, theater, highway, or walk away from home is ordinarily safe while still lacking direct corrective experience under the exact conditions that activate the agoraphobic fear system.
In a systematic review of predictors and moderators of CBT outcome for panic disorder and agoraphobia, Porter and Chambless found that agoraphobic avoidance was the most consistent predictor of less improvement across the included studies. The finding does not mean severe avoidance makes recovery impossible. It means the degree of avoidance is clinically important and should be assessed directly rather than inferred from how distressed someone says they feel.
Overt avoidance and hidden avoidance
Overt avoidance is visible: not taking public transportation, not entering crowded places, refusing to drive on certain roads, not going far from home, avoiding enclosed spaces, or never being alone outside. Hidden avoidance can be subtler. A person may technically enter the situation but only under narrow conditions—for example, only with one companion, only at quiet times, only beside an exit, only after repeated reassurance, only while continuously monitoring bodily sensations, or only when immediate escape is guaranteed.
Those conditions can function as safety behaviors when the person believes catastrophe is prevented by the condition rather than learning that the situation can be managed without it. Yet safety behavior is not a moral category and should not be treated with a blanket rule. A meta-analysis by Meulders and colleagues found no compelling overall evidence that simply adding or removing safety-seeking behavior uniformly changes exposure outcomes across studies. The clinical question is what the behavior is doing in the individual fear system.
Adaptive support is not a treatment failure
Reasonable safety precautions, disability accommodations, mobility aids, prescribed medication, rescue treatment for a genuine medical condition, and practical support are not automatically maladaptive because they reduce distress. Recovery should not be defined as abandoning necessary support. The useful distinction is whether a behavior enables meaningful functioning or whether it has become a rigid condition that prevents feared predictions from being tested and progressively narrows life.
What Improvement in Agoraphobia Can Look Like
Improvement often becomes visible first in behavior rather than in a dramatic change in emotion. A person may still notice anticipatory anxiety before leaving home but spend less time negotiating with it. They may still prefer an aisle near an exit but can choose another one. They may still feel dizziness or unreality on a train but remain on board. These changes matter because anxiety is losing control over action.
Your usable world gets larger
One of the clearest signs of recovery is increased range. The person can go farther from home, use more routes, enter a wider variety of places, remain out longer when desired, or tolerate more variability in crowds, traffic, queues, distance, and unfamiliar settings. The exact locations are individual. The important change is that life is less organized around a shrinking map of permitted places.
You need fewer special conditions to do ordinary things
Progress can appear as reduced dependence on a particular companion, exit, seat, route, time of day, reassurance ritual, or escape plan. A person may begin with support and later discover that support is optional rather than necessary. The shift from “I can do this only if my safe person is here” to “I prefer company, but I can cope on my own” is a meaningful behavioral change.
Function can recover before fear disappears
Work attendance, education, caregiving, shopping, exercise, social participation, travel, medical appointments, and independent time outside the home can improve while symptoms remain. In a randomized study of people with panic disorder with agoraphobia, Telch and colleagues found substantial quality-of-life impairment at baseline and improvement after cognitive-behavioral treatment. Because the study used an older panic-disorder-with-agoraphobia framework, it supports the importance of function without defining a universal modern recovery rate for standalone agoraphobia.
Anxiety becomes information instead of an automatic stop signal
A racing heart, dizziness, trembling, heat, nausea, unreality, or a wave of fear can remain unpleasant. Recovery becomes visible when the sensation no longer automatically means “leave now,” “I cannot continue,” or “this proves the place is dangerous.” The person gains more options between noticing anxiety and acting on it.
Setbacks become easier to contain
A difficult day may still lead to an early exit or a canceled plan. Improvement is visible when that event remains local rather than becoming a new rule for the next week or month. The person can review what happened, return to the situation or a manageable version of it, and prevent one episode from turning into a broad expansion of avoidance.
Do Panic Attacks Have to Stop for Agoraphobia to Improve?
No. Panic attacks and agoraphobia are related but distinct clinical phenomena. A person can have agoraphobia without panic disorder, and a person with panic disorder may or may not have agoraphobia. Recovery from agoraphobia should therefore be judged primarily by the agoraphobic fear-and-avoidance pattern and its impact on functioning, not by whether panic attacks have reached exactly zero.
Older panic-disorder-with-agoraphobia research illustrates why this matters. Ramnerö and Öst examined different aspects of change after behavioral treatment and found that changes in avoidance were related to quality of life and negative affect in ways that were not captured simply by panic-free status. The sample belongs to an older diagnostic framework, but the study supports a useful clinical distinction: the disappearance of panic attacks is not a complete measure of whether agoraphobic restriction has resolved.
Why Residual Avoidance Can Matter After You Feel Much Better
Residual avoidance means that some feared situations or safety conditions remain after major improvement. It can be easy to miss because the most distressing symptoms may have fallen substantially. A person may report that panic is rare yet still avoid highways, public transportation, crowded stores, long lines, being alone outside, or meaningful travel. Those restrictions may continue to matter for independence and quality of life.
Long-term follow-up studies conducted under older panic-disorder-with-agoraphobia frameworks suggest that residual avoidance can also be relevant to relapse risk. In one long-term follow-up, Fava and colleagues reported that residual agoraphobic avoidance after exposure treatment was associated with a less favorable course. In a randomized maintenance-CBT trial, White and colleagues found that residual agoraphobic symptoms after acute CBT independently predicted time to relapse during follow-up.
These studies should not be turned into a personalized relapse calculator. Their participants, diagnostic systems, and treatments differ from every current individual case. The justified conclusion is narrower: feeling better while continuing to organize important parts of life around avoidance can leave meaningful disability and vulnerability in place, so recovery assessment should include what the person is actually able to do.
What Does the Evidence Say About Long-Term Improvement?
The treatment literature supports meaningful improvement, while long-term certainty becomes thinner as follow-up periods lengthen. A 2022 systematic review and network meta-analysis included 136 randomized trials of psychotherapies for panic disorder with or without agoraphobia and found CBT remained more efficacious than treatment as usual after trials at high risk of bias were removed. Because the evidence base combines panic-disorder populations with and without agoraphobia, it is stronger evidence for the treatment family than for a precise recovery percentage in modern standalone agoraphobia.
A systematic review and meta-analysis of long-term CBT outcomes across anxiety-related disorders found benefits for panic disorder with or without agoraphobia through the first year after treatment compared with control conditions. Beyond 12 months, the pooled effect for that diagnostic group was no longer statistically significant, and the authors emphasized that many included studies were of low quality and that long-term relapse reporting was limited. The evidence supports sustained benefit for many people while arguing against promises of permanent cure.
Individual long-term studies also show that gains can persist. A two-year follow-up study of 146 people with panic disorder with agoraphobia found that most treatment responders maintained clinically meaningful change, although approximately one third continued to have meaningful residual problems. That finding captures the evidence better than either extreme: durable improvement is possible, and residual difficulties remain important.
How CBT and Exposure Fit Into Recovery
CBT for agoraphobia typically targets the cycle connecting feared situations, catastrophic predictions, anxiety or panic-like sensations, escape, avoidance, and safety behavior. Exposure is central because it creates opportunities to approach what fear has excluded and learn under conditions that matter in everyday life. The NHS agoraphobia treatment guidance describes CBT as commonly combined with exposure and explains the graded logic of beginning with manageable goals and progressing toward more challenging ones.
This recovery article does not turn that principle into a personalized exposure prescription. Dose, pacing, target selection, medical considerations, disability, trauma history, comorbidity, previous treatment response, and access all matter. The dedicated graded-exposure guide explains fear hierarchies, prediction testing, repetition, safety behavior, and inhibitory learning in depth.
Recovery is about new learning, not proving toughness
A useful exposure is not defined by producing the maximum possible fear. It is designed to test a meaningful prediction and expand behavior. Breuninger, Tuschen-Caffier, and Svaldi reviewed cognitive change and self-efficacy in exposure treatment for agoraphobia and found large cognitive improvement across the included studies, with mediation research generally supporting cognitive change, including self-efficacy, as a probable mechanism. The causal details remain an active research question.
The practical implication is that capability can grow before calmness becomes consistent. “I was anxious and still completed the trip” may represent stronger recovery learning than “I waited until I felt perfectly safe before leaving.” Repeated experiences of functioning under imperfect internal conditions can reduce the need to make absence of anxiety a prerequisite for living.
How to Measure Agoraphobia Recovery Without Reducing It to One Score
A useful recovery picture combines symptoms, behavior, and functioning. Instead of asking only “How anxious was I?”, assessment can ask how many situations remain avoided, how much planning is organized around escape, whether a companion is required, how often activities are canceled, how wide the person’s travel range has become, how flexible routes and timing are, how quickly the person returns after a setback, and how much work, study, relationships, health care, recreation, or independence have been restored.
Formal measures can add structure. The American Psychiatric Association’s Severity Measure for Agoraphobia—Adult is a 10-item measure focused on symptom severity during the previous seven days and can be used repeatedly to follow change. A score is not a diagnosis, and a lower score alone does not establish recovery. Clinical assessment and functioning still matter.
The same principle applies to online “agoraphobia tests.” Screening or symptom questionnaires can identify patterns worth discussing, while diagnosis requires assessment of the focus of fear, duration, number and type of situations, avoidance or endurance, disproportionality, impairment, differential diagnosis, medical factors, substances, and other mental health conditions. See Agoraphobia Test: What Screening Can and Cannot Tell You.
What Is the Difference Between a Setback and a Relapse?
A setback is a temporary increase in symptoms or avoidance that does not necessarily represent a sustained return of the disorder. A stressful week, illness, sleep disruption, an unexpected panic attack, bereavement, travel, a difficult exposure, or a period with fewer opportunities to practice can make old fears more available again. Fluctuation does not by itself erase recovery.
Relapse usually refers to a more sustained return of clinically significant symptoms after meaningful improvement or remission. Studies define relapse differently, so there is no single online threshold that can determine whether a person has relapsed. Function is informative: if the person’s world is progressively shrinking again, previously recovered situations are being dropped, and avoidance is becoming the default response across days or weeks, reassessment is more useful than arguing over the label.
Recent aftercare research shows why individual trajectories matter. A 2024 naturalistic study followed people with agoraphobia for three months after discharge and found relatively stable average symptom severity at the group level but highly heterogeneous individual courses. Wilhelm and colleagues designed the study to inform adaptive aftercare rather than to define relapse, but the result illustrates a general point: group averages can hide very different personal patterns.
Does a Bad Exposure Mean Recovery Is Going Backward?
No single exposure determines the direction of recovery. A person can enter a situation and experience intense fear, leave earlier than planned, or need more support than usual without losing previous learning. Anxiety naturally varies with context, sleep, physical illness, stress, stimulant use, unfamiliar settings, and many other factors.
The more useful question is what happens next. If a difficult experience becomes evidence that the situation must again be excluded from life, avoidance can spread. If it becomes information—perhaps the task was too large, the prediction was unclear, a medical issue needs evaluation, or more support is needed—the plan can be adjusted without treating the event as proof of failure.
Why Recovery Can Feel Slower Than Expected
Agoraphobia can affect systems that daily life depends on: transportation, shopping, work attendance, being alone, medical care, caregiving, and travel. Expanding those systems can require repeated learning across multiple settings rather than one dramatic breakthrough. Progress may therefore look uneven even when the overall direction is favorable.
The recovery target may be too broad
“Leave the house without anxiety” combines an action with an internal state that cannot be commanded directly. More specific targets—entering a particular place, staying for a chosen purpose, traveling a certain route, reducing one rigid condition, or completing an activity that matters—make learning observable. Recovery is easier to evaluate when the unit of change is concrete.
A safety condition may be carrying the success
Sometimes the person is doing more but attributes every successful outcome to a safety condition: the companion, a guaranteed exit, constant pulse checking, a particular seat, or repeated reassurance. A clinician can help determine whether the condition is adaptive support, medically necessary, or a fear-maintaining behavior that prevents the feared prediction from being tested.
The diagnosis or formulation may need another look
Persistent difficulty can also reflect a mismatch between the treatment target and the actual problem. Social anxiety disorder, specific phobia, panic disorder, PTSD, OCD, depression, substance-related symptoms, vestibular disorders, cardiovascular conditions, respiratory conditions, medication effects, and other medical or psychological factors can overlap with parts of an agoraphobia presentation. Recovery planning improves when the organizing problem is identified correctly rather than assuming every episode of fear outside the home is agoraphobia.
Medical Symptoms Should Not Be Automatically Reclassified as Anxiety
Agoraphobia can involve panic-like physical symptoms, but symptom overlap does not establish psychological causation. New, severe, unusual, or unexplained chest pain, fainting, significant breathing difficulty, new neurologic symptoms, sustained palpitations, or other medically concerning signs deserve appropriate medical evaluation. A previous anxiety diagnosis does not make every later symptom an anxiety symptom.
This matters during recovery because exposure should test feared predictions in situations that are reasonably safe; it should not be used to override unresolved medical warning signs. If a person has a medical condition, disability, pregnancy-related issue, medication change, or another health factor that affects activity, treatment planning may need coordination with an appropriate clinician.
What Role Does Medication Play in Recovery?
Medication can be part of treatment for some people, but recovery should not be defined as being medication-free. The relevant question is whether symptoms, avoidance, and functioning improve within a safe, evidence-based treatment plan. Indications, adverse effects, dependence risk, discontinuation effects, and monitoring differ by drug class and diagnosis, and medication changes should be discussed with the prescribing clinician.
The agoraphobia medication evidence base is also diagnostically mixed. Much pharmacotherapy research relevant to agoraphobic symptoms comes from panic-disorder samples with or without agoraphobia rather than from modern standalone agoraphobia cohorts. That evidence can inform shared decision-making, but it should not be relabeled as if every medication had equally direct evidence for isolated agoraphobia. The dedicated agoraphobia treatment guide keeps those distinctions explicit.
Can Digital or Online CBT Support Recovery?
Structured internet-delivered CBT can help some people with panic disorder and agoraphobia. A systematic review and meta-analysis by Stech and colleagues found that internet-delivered CBT outperformed waiting-list and information controls for panic and agoraphobia symptom severity, with benefits maintained at three-to-six-month follow-up in the available studies. Comparisons with active treatments were fewer, study quality varied, and heterogeneity was high.
A 2025 meta-analytic review by Jung and colleagues also reported beneficial effects of digital CBT for panic disorder and agoraphobia while emphasizing heterogeneity in treatment content and risk of bias. Digital treatment is therefore best understood as a delivery format whose usefulness depends on the intervention, clinical fit, support, severity, and safety. Evidence for structured digital CBT should not be generalized to every wellness app, conversational chatbot, or unvalidated online program.
What Recovery Can Look Like After Severe or Housebound Agoraphobia
Severe agoraphobia can narrow life to a very small zone and sometimes make leaving home extremely difficult. In that situation, recovery can begin with changes that look modest from the outside but are clinically meaningful: tolerating the doorway, spending time outside the immediate safe zone, allowing a support person to be farther away, entering a nearby location, or completing part of a previously impossible route.
The principle remains the same: the usable world expands. A person who is housebound does not need to prove recovery with a dramatic first attempt at a distant or crowded setting. A graded plan can establish repeated and generalizable learning. When severe avoidance itself blocks access to care, telehealth or structured remote treatment may provide an entry point, while the long-term behavioral target still concerns real-world functioning.
How Family and Friends Can Help Without Becoming Part of the Avoidance System
Support can make recovery more accessible. A family member or friend can help with transportation, encouragement, treatment attendance, planned exposure, or practical barriers. The challenge is to avoid turning support into an absolute safety condition. If the person comes to believe that one particular companion is the only reason a situation is survivable, the support relationship can unintentionally become part of the fear structure.
A useful clinical goal is flexible support: enough help to increase participation, with a plan for greater independence where appropriate. A companion may be present for an early step, wait farther away later, and eventually become optional. The pace depends on severity, disability, risk, treatment goals, and what the support is actually doing.
When Should Agoraphobia Recovery Be Reassessed?
Reassessment is useful when avoidance remains extensive, functioning is not improving, treatment repeatedly produces only short-lived gains, panic or depression is worsening, substance use is complicating symptoms, medical questions remain unresolved, or the person is becoming increasingly housebound. It is also appropriate when the original diagnosis no longer seems to explain the pattern.
Reassessment does not mean the previous effort was wasted. It can identify a different maintaining process, a comorbid disorder, insufficient treatment dose, an inaccessible format, unaddressed safety behavior, a medical contributor, or a need for a different level of care. Recovery planning is often iterative.
A Practical Way to Think About Progress
The most useful question is not “Did I feel anxious today?” It is “What did anxiety prevent today, and is that changing over time?” A recovery trajectory becomes visible when choices increase. The person can go because they want or need to go, stay because the activity matters, leave for ordinary reasons rather than automatic escape, and tolerate uncertainty about whether anxiety will appear.
That is why avoidance matters so much. Symptom relief is valuable, but a low-anxiety life achieved by eliminating feared places remains highly restricted. Recovery becomes more robust when symptom improvement and behavioral freedom move together.
Frequently Asked Questions About Agoraphobia Recovery
Can you fully recover from agoraphobia?
Substantial and sometimes very extensive recovery is possible. Evidence supports CBT and exposure-based treatment, and long-term studies show that meaningful gains can persist. Research cannot guarantee every individual a permanent, symptom-free cure. The most useful picture of recovery combines sustained changes in avoidance, functioning, symptoms, and flexibility.
How long does agoraphobia recovery take?
There is no universal timeline. Severity, duration, degree of avoidance, functional impairment, comorbidity, medical factors, treatment access, treatment fit, and opportunities to practice new behavior can all matter. A published treatment schedule is a protocol, not a deadline by which an individual must recover.
Is leaving the house enough to prove I am recovering?
Leaving the house can be a major achievement, but recovery is broader. A person may leave home while still avoiding transportation, crowds, enclosed spaces, distance, being alone, or any situation without a specific safety condition. The relevant pattern is whether the usable range of life is becoming wider and more flexible.
Can I recover even if I still get panic attacks?
Yes. Panic attacks and agoraphobia are distinct. Improvement in situational fear, avoidance, independence, and functioning can occur even if panic-like episodes have not disappeared completely. Recurrent unexpected panic attacks with persistent concern or behavior change may also warrant assessment for panic disorder.
Does recovery mean I should stop all safety behaviors?
No blanket rule is justified. Some safety behaviors can interfere with learning; others are adaptive support, disability accommodations, or medically necessary precautions. Their function matters. Prescribed medication or medical safety measures should not be stopped merely to make an exposure feel more “pure.”
Is a setback the same as relapse?
No. A setback can be a temporary symptom spike or return of avoidance. Relapse generally refers to a more sustained return of clinically significant problems after improvement or remission. Definitions vary across studies, so the practical signal is whether restriction is persisting and spreading.
Should anxiety go to zero during exposure?
No. Anxiety may decrease during an exposure, but zero anxiety is not required for useful learning. Contemporary exposure models emphasize prediction testing, approach behavior, variability, and new learning. A person can finish an exercise while still anxious and have made meaningful progress.
How do I know whether I am improving if my anxiety still feels high?
Track behavior and function alongside distress. Are you avoiding fewer situations? Traveling farther? Depending less on a companion? Returning sooner after a difficult experience? Resuming valued roles? Spending less time planning escape? Those changes can show recovery even before subjective anxiety consistently falls.
Can agoraphobia come back after treatment?
Symptoms and avoidance can recur in some people, and long-term studies document relapse in a proportion of treated samples. A return of fear does not erase previous learning. Early recognition of renewed avoidance and timely reassessment can help prevent a temporary return of symptoms from becoming a broader restriction.
When should I seek professional help?
Professional assessment is appropriate when fear or avoidance is persistent, significantly restricts daily life, keeps expanding, creates dependence on others, prevents necessary health care or work, or is difficult to distinguish from another mental or physical health condition. Urgent or medically concerning physical symptoms should be evaluated medically rather than assumed to be anxiety.
Related Articles
References
American Psychiatric Association. (n.d.). Severity Measure for Agoraphobia—Adult. Official measure
Breuninger, C., Tuschen-Caffier, B., & Svaldi, J. (2019). Dysfunctional cognition and self-efficacy as mediators of symptom change in exposure therapy for agoraphobia: Systematic review and meta-analysis. Behaviour Research and Therapy, 120, 103443. PubMed
Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: An inhibitory learning approach. Behaviour Research and Therapy, 58, 10–23. PubMed
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., Ruini, C., Mangelli, L., & Belluardo, P. (2001). Long-term outcome of panic disorder with agoraphobia treated by exposure. Psychological Medicine, 31(5), 891–898. PubMed
Gloster, A. T., Hauke, C., Höfler, M., Einsle, F., Fydrich, T., Hamm, A., Ströhle, A., & Wittchen, H.-U. (2013). Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: A two-year follow-up study. Behaviour Research and Therapy, 51(12), 830–839. PubMed
Jung, H. W., Jang, K. W., Nam, S., Kim, A., Lee, J., Ahn, M. E., Lee, S.-K., Kim, Y. J., Shin, J.-K., & Roh, D. (2025). Digital cognitive behavioral therapy for panic disorder and agoraphobia: A meta-analytic review of clinical components to maximize efficacy. Journal of Clinical Medicine, 14(5), 1771. PubMed
Meulders, A., Van Daele, T., Volders, S., & Vlaeyen, J. W. S. (2016). The use of safety-seeking behavior in exposure-based treatments for fear and anxiety: Benefit or burden? A meta-analytic review. Clinical Psychology Review, 45, 144–156. PubMed
National Health Service. (n.d.). Treatment — Agoraphobia. NHS
National Institute of Mental Health. (n.d.). Phobias and phobia-related disorders. NIMH
Papola, D., Ostuzzi, G., Tedeschi, F., et al. (2022). Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: Systematic review and network meta-analysis of randomised controlled trials. British Journal of Psychiatry, 221(3), 507–519. PubMed
Porter, E., & Chambless, D. L. (2015). A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia. Clinical Psychology Review, 42, 179–192. PubMed
Ramnerö, J., & Öst, L.-G. (2007). Panic and avoidance in panic disorder with agoraphobia: Clinical relevance of change in different aspects of the disorder. Journal of Behavior Therapy and Experimental Psychiatry, 38(1), 29–39. PubMed
Stech, E. P., Lim, J., Upton, E. L., & Newby, J. M. (2020). Internet-delivered cognitive behavioral therapy for panic disorder with or without agoraphobia: A systematic review and meta-analysis. Cognitive Behaviour Therapy, 49(4), 270–293. PubMed
Telch, M. J., Schmidt, N. B., Jaimez, T. L., Jacquin, K. M., & Harrington, P. J. (1995). Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. Journal of Consulting and Clinical Psychology, 63(5), 823–830. PubMed
van Dis, E. A. M., van Veen, S. C., Hagenaars, M. A., et al. (2020). Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: A systematic review and meta-analysis. JAMA Psychiatry, 77(3), 265–273. PubMed
White, K. S., Payne, L. A., Gorman, J. M., Shear, M. K., Woods, S. W., Saksa, J. R., & Barlow, D. H. (2013). Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial. Journal of Consulting and Clinical Psychology, 81(1), 47–57. PubMed
Wilhelm, M., Moessner, M., Jost, S., et al. (2024). Development of decision rules for an adaptive aftercare intervention based on individual symptom courses for agoraphobia patients. Scientific Reports, 14, 3056. PubMed Central
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. WHO